Good morning :)
$
E

Entero Therapeutics, Inc.

GRDX

NASDAQ
$2.48% (+2.48)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Biotechnology

Micro Cap

With a market cap of $10.3M the stock is ranked 5463

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.45
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-11.66
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

Company Profile

Peers

Peers

P/E Ratio
56.18
56.18
1Y Return
206.88%
206.88%
Buy Reco %
75.00
75.00
P/E Ratio
75.21
75.21
1Y Return
41.09%
41.09%
Buy Reco %
83.33
83.33
P/E Ratio
29.84
29.84
1Y Return
104.12%
104.12%
Buy Reco %
P/E Ratio
1Y Return
74.09%
74.09%
Buy Reco %
100.00
100.00
P/E Ratio
10.99
10.99
1Y Return
43.56%
43.56%
Buy Reco %
53.33
53.33

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Entero Therapeutics, Inc. -0.45-
GE Vernova LLC56.1823.843.84
Vistra Energy Corp75.2121.171.40

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

-12.2
0
-1.2
-0.9
-1.1
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Revenue
Net Income
Financial YearQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Total Revenue-----000.0900
Net Income-4.07-4.18-3.43-4.105.56-2.58-12.23-1.25-0.99-1.15
Net Profit Margin--------1315.14%--
Loading...